Abacus Parenterals Drugs Ltd.

Abacus Parenteral Drugs Limited (APDL) manufactures high-quality lifesaving parenteral products, which reach over 30 million patients each year.

Established in 2009, APDL employs state-of-the-art BFS technology to manufacture a diverse product portfolio consisting of 50 IV-infusions and Ear/ Eyes/Nose Drops. The plant, which is ISO certified, EAC GMP compliant and approved by multiple regulatory bodies, is a successful example of world-class manufacturing in Africa.

APDL is a key supplier to NMS, providing efficacious affordable products within short lead-times. APDL consistently manufactures and maintains adequate inventory earmarked for NMS supply, to ensure timely delivery for NMS’ beneficiaries.